Bank of Montreal’s Lexaria Bioscience LEXX Stock Holding History

Bank of Montreal’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.86K	Hold	936	–	–	﹤0.01%	3689
2026 Q1	$10.9K	Sell	936 -3	-0.3%	-$33	﹤0.01%	3550
2025 Q4	$8.69K	Buy	939 +3	+0.3%	+$43	﹤0.01%	3434
2025 Q3	$13.3K	Hold	936	–	–	﹤0.01%	3334
2025 Q2	$12.2K	Hold	936	–	–	﹤0.01%	3346
2025 Q1	$24K	Buy	936 +3	+0.3%	+$76	﹤0.01%	3189
2024 Q4	$29.4K	Hold	933	–	–	﹤0.01%	3202
2024 Q3	$42.3K	Buy	+933	New	+$44.5K	﹤0.01%	3444
2021 Q2	–	Sell	-2	Closed	–	–	4365
2021 Q1	$0	Buy	+2	New	+$176	﹤0.01%	5238

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal's LEXX Position: Q2 2026 in Review

Bank of Montreal held its Lexaria Bioscience (LEXX) position steady in Q2 2026 at 936 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

Bank of Montreal first reported a position in LEXX in Q1 2021 and has held it in 9 quarters since. The position peaked at $42.3K in Q3 2024. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

Bank of Montreal held 936 shares of Lexaria Bioscience worth $7.86K as of Q2 2026.
Bank of Montreal left its Lexaria Bioscience share count unchanged in Q2 2026.
Lexaria Bioscience made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3689 holding.
Bank of Montreal first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 9 quarters since.
Bank of Montreal's Lexaria Bioscience position peaked at $42.3K in Q3 2024.
29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.